Skin | Jotup

Super Absorbent Polymers Market Projected to Reach $13.46 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on:

Wednesday, May 1, 2024

However, challenges such as fluctuating raw material prices, concerns over non-biodegradable SAPs' environmental impact, and pursuing sustainable options are shaping the market dynamics.

Key Points:

However, challenges such as fluctuating raw material prices, concerns over non-biodegradable SAPs' environmental impact, and pursuing sustainable options are shaping the market dynamics.
Super absorbent polymers (SAPs) are crucial in today's rapidly evolving industries owing to their unique properties tailored to meet specific industry needs.
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Super Absorbent Polymers Market.
"Dive into the Super Absorbent Polymers Market Landscape: Explore 180 Pages of Insights, 472 Tables, and 24 Figures"

Super Absorbent Polymers Market Projected to Reach $13.46 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on:

Wednesday, May 1, 2024

However, challenges such as fluctuating raw material prices, concerns over non-biodegradable SAPs' environmental impact, and pursuing sustainable options are shaping the market dynamics.

Key Points:

However, challenges such as fluctuating raw material prices, concerns over non-biodegradable SAPs' environmental impact, and pursuing sustainable options are shaping the market dynamics.
Super absorbent polymers (SAPs) are crucial in today's rapidly evolving industries owing to their unique properties tailored to meet specific industry needs.
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Super Absorbent Polymers Market.
"Dive into the Super Absorbent Polymers Market Landscape: Explore 180 Pages of Insights, 472 Tables, and 24 Figures"

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS

Retrieved on:

Tuesday, April 30, 2024

NASHVILLE, Tenn., April 30, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.

Key Points:

NASHVILLE, Tenn., April 30, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.
A conference call will be held on May 7 at 4:30 p.m. Eastern Time to discuss the results.
Once registered, participants can dial in from their phone using a dial-in and PIN number that will be provided to them.
Cumberland Pharmaceuticals is a specialty pharmaceutical company focused on providing unique products that improve patient care.

NEW AMERICAN ACADEMY OF DERMATOLOGY SURVEY: INCREASING NUMBER OF AMERICANS AT RISK OF SKIN CANCER DESPITE KNOWING HOW TO PROTECT THEMSELVES

Retrieved on:

Tuesday, April 30, 2024

UPF, American Academy, Cancer, Bleeding, Risk, FAAD, Skin, Burn, UVB, Health, Sunburn, Skin cancer, Tanning, Melanoma, Cheek, AAD, Eating, Diagnosis, SPF, UV, Clothing, Cosmetics

ROSEMONT, Ill., April 30, 2024 /PRNewswire/ -- Abby Weiner knew the dangers of unprotected sun exposure long before she was diagnosed with skin cancer. As someone with fair skin and freckles, the 43-year-old mother of three says she has always been diligent about wearing hats and using sunscreen when sitting at a beach or a pool but didn't think about the sun exposure she was getting elsewhere until she was diagnosed with melanoma on her cheek in 2023.

Key Points:

The most avoidable risk factor for skin cancer, including melanoma—the deadliest type of skin cancer—is exposure to the sun.
In recognition of Skin Cancer Awareness Month in May and Melanoma Monday® on May 6, the American Academy of Dermatology (AAD) is encouraging the public to practice safe sun to reduce their risk of skin cancer.
"Data shows a staggering truth: one in five Americans will be diagnosed with some form of skin cancer in their lifetime.
To protect yourself from the sun and reduce your risk of skin cancer, the AAD recommends that everyone:
Seek shade.

Dermatology Association of Radiation Therapy (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma Skin Cancer in Seven States

Retrieved on:

Monday, April 29, 2024

The proposed LCD at issue, DL39808 " Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) ," would affect residents in North and South Carolina, Virginia, West Virginia, Alabama, Georgia and Tennessee.

Key Points:

The proposed LCD at issue, DL39808 " Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) ," would affect residents in North and South Carolina, Virginia, West Virginia, Alabama, Georgia and Tennessee.
The DART filing noted, "In its current form, the LCD is fundamentally misdirected, misguided, and inappropriate.
It would altogether remove any semblance of patient choice or physician clinical decision making for patients who are diagnosed with NMSC.
At the outset, DART underscores that the proposed LCD was filed as a Medicare Part A policy.

AirSculpt® Relocates and Expands to New Location to Meet Market Demand

Retrieved on:

Monday, April 29, 2024

MIAMI, Patient, Georgia State Route 237, United, Plasma, Skin

Also, the company's popular AirSculpt®+ skin tightening procedure has been added to the clinic's list of current offerings.

Key Points:

Also, the company's popular AirSculpt®+ skin tightening procedure has been added to the clinic's list of current offerings.
"We're delighted to announce our new Buckhead office in the prime Lenox Overlook area," said Todd Magazine, Chief Executive Officer at AirSculpt® Technologies.
AirSculpt® + is an additive procedure to AirSculpt® fat removal that offers an additional skin tightening effect.
For additional information on AirSculpt®, the new Atlanta location or for information about scheduling a virtual or in-person consultation at any of the 27 centers, visit airsculpt.com.

Life Time Opens 12th Athletic Country Club in Dallas-Fort Worth with Debut of Life Time Las Colinas; Waitlist Also Open for Westlake Location

Retrieved on:

Friday, April 26, 2024

GTX, Learning, Skin, LTH, Lifetime, Real estate development, Yoga, Family, Nail, Growth, Alpha

DALLAS, April 26, 2024 /PRNewswire/ -- Life Time (NYSE: LTH) continues its growth in Texas with two new athletic country clubs opening in the coming months. Located in Irving, Life Time Las Colinas opens April 26. Later this summer, the nearby Life Time Westlake will debut. A waitlist is now open.

Key Points:

For more information on features and amenities at Life Time Las Colinas, visit the club's website , or call 214-231-5600.
You can learn more about Life Time Westlake and join the waitlist for the club ahead of its summer opening by clicking here .
Life Time debuted in the Dallas-Fort Worth market with the opening of Life Time Plano in 2003.
Life Time is continuing to grow its athletic country club locations nationwide through 2024.

Sharon Personal Care Introduces World's First Vitamin-Based Multifunctional Preservation Platform

Retrieved on:

Wednesday, April 17, 2024

Pigment, Hydrophile, B3, Nicotinamide, Vitamin B3, GMO, Research, Growth, Skin, Cosmetics

Trezzo sull'Adda, Italy--(Newsfile Corp. - April 17, 2024) - Sharon Personal Care, a global supplier of innovative, environmentally friendly ingredient solutions for a broad range of personal care products, introduced AquaVITA®, the world's first vitamin-based multifunctional preservation platform, today at in-cosmetics 2024, being held in Paris, France.

Key Points:

Trezzo sull'Adda, Italy--(Newsfile Corp. - April 17, 2024) - Sharon Personal Care, a global supplier of innovative, environmentally friendly ingredient solutions for a broad range of personal care products, introduced AquaVITA®, the world's first vitamin-based multifunctional preservation platform, today at in-cosmetics 2024, being held in Paris, France.
These synergies enable Sharon to turn vitamin B3 into a mild, green, safe, and sustainable antimicrobial preservation solution.
It combines antimicrobial efficacy and clinically proven skin care benefits, such as reduced pigmentation, skin brightening, and skin barrier strengthening," says Naama Eylon, CEO of Sharon Personal Care.
Sharon Personal Care introduced AquaVITA®, the world's first vitamin-based multifunctional preservation platform, today at in-cosmetics 2024 in Paris, France.

"Rebel With a Kickstand" Launches Women's Triathlon Brand

Retrieved on:

Thursday, April 18, 2024

Sport, Individual, Female, Woman, Skin, Athlete, Interior design

New York, New York--(Newsfile Corp. - April 18, 2024) - Rebel With a Kickstand, the women's triathlon brand, empowers women in sports with unique designs featuring original art.

Key Points:

New York, New York--(Newsfile Corp. - April 18, 2024) - Rebel With a Kickstand, the women's triathlon brand, empowers women in sports with unique designs featuring original art.
Rebel With a Kickstand stands out as a brand that defies the norm, offering activewear that is not only functional but also expressive.
The brand prides itself on creating kits that feel like a second skin, allowing athletes to focus on goals rather than being hindered by the gear.
Over the past decade, Rebel, Tremain's training alter ego, has become a symbol of strength, resilience, and individuality within the women's triathlon community.

Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer

Retrieved on:

Wednesday, April 24, 2024

University, CMO, Safety, NDA, Skin, Leo Pharma, Dermatology, Doctor of Philosophy, Freedom, Engineering, Patient, Doctor of Pharmacy, Secukinumab, Psoriasis, Therapy, Celgene, Biotechnology, Chronic kidney disease, Pharmaceutical industry

WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced the strengthening of its leadership team with the addition of two experienced executives.

Key Points:

Joana Goncalves, MBChB, will serve as Oruka’s Chief Medical Officer, effective April 18, 2024.
Dr. Goncalves brings two decades of leadership experience in dermatology clinical development and medical affairs.
Oruka also announced that Eugenia Levi, PharmD, will join the company as Vice President of Medical Affairs.
Her extensive leadership experience will prove invaluable as we advance our portfolio of potentially best-in-class antibodies and build a high-performing team,” said Lawrence Klein, PhD, Chief Executive Officer of Oruka Therapeutics.